Kevin shares how to be your best advocate

GRAPHIC: 

 [10-SECOND COUNTDOWN BEGINS]

On-screen Text:

SKYRIZI is a prescription medicine used to treat adults with active psoriatic arthritis (PsA).

SAFETY CONSIDERATIONS

SKYRIZI may cause serious side effects, including:

  • Serious allergic reactions: Stop using SKYRIZI and get emergency medical help right away if you get any symptoms of a serious allergic reaction. 
  • Infections: SKYRIZI may increase your risk of infections. Before starting treatment, your doctor should check you for infections and tuberculosis. Tell your doctor right away if you have an infection or symptoms of one. 

Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. 

Also, tell your doctor if you plan to or recently received a vaccine.

Please see additional Important Safety Information near the end of this video. Please see the full link for the Full Prescribing Information, including the Medication Guide, for SKYRIZI. 

GRAPHIC:
Skyrizi®
risankizumab-rzaa 

On-screen Text: 

KEVIN SHARES HOW TO BE YOUR BEST ADVOCATE 

Kevin:

I love to take what I’ve learned from my own experiences, and share that with others to perhaps help them. 

On-screen Text:  

KEVIN

SKYRIZI PATIENT WITH ACTIVE PSORIATIC ARTHRITIS AND PLAQUE PSORIASIS 

Kevin:

My psoriatic arthritis impacted my life on a daily basis. I would avoid mowing the lawn, playing with my kids.

Kevin:

I decided I have to do something about this.  

Kevin:

I have psoriatic arthritis. But I also have a life, and I need to live life.

Kevin:

I made the decision to go to the doctor.

Kevin:

I wanted to understand fully why was I going through what I was going through. And so, I asked very specific, very pointed questions.

Kevin:

I had to advocate for myself.   

On-screen Text: 

SKYRIZI LOGO

Kevin:

And that’s how I got on SKYRIZI. 

Kevin:

SKYRIZI helps me move with less joint pain and stiffness.

On-screen Text: 

LESS JOINT PAIN, STIFFNESS, AND SWELLING

In PsA clinical trials, a majority experienced a 20% improvement in symptoms at week 24.

Kevin:

With SKYRIZI, it’s not as hard to do my everyday activities, like playing with my grandkids.

Kevin:

I would encourage anyone to advocate for themselves with their physician. 

Kevin:

Do the research. Talk to support groups. Talk to maybe other patients. 

Kevin:

Find out all the information you can. But, most importantly, talk to your doctor.

Kevin:

Describe the symptoms that are happening and get that medical advice. 

Kevin:

But don’t give up. Keep searching. Keep advocating.  

Kevin:

There are options, and there’s hope out there.

V.O./On-screen Text:  

IMPORTANT SAFETY INFORMATION AND USE

SKYRIZI® (risankizumab-rzaa) USE
SKYRIZI is a prescription medicine used to treat adults with active psoriatic arthritis (PsA).

Important Safety Information 
What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?

SKYRIZI is a prescription medicine that may cause serious side effects, including:

Serious allergic reactions:

  • Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
  • fainting, dizziness, feeling lightheaded (low blood pressure)
  • swelling of your face, eyelids, lips, mouth, tongue, or throat
  • trouble breathing or throat tightness
  • chest tightness
  • skin rash, hives
  • itching

Infections:

SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.

  • Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
    - fever, sweats, or chills
    - cough
    - shortness of breath
    - blood in your mucus (phlegm)
    - muscle aches
    - warm, red, or painful skin or sores on your body different from your psoriasis 
    - weight loss
    - diarrhea or stomach pain
    - burning when you urinate or urinating more often than normal

 

Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.

Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, 
including if you:

  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
  • have an infection that does not go away or that keeps coming back.
  • have TB or have been in close contact with someone with TB.
  • have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
  • are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
  • become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of SKYRIZI?

SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”

The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.

These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about  
side effects.

Use SKYRIZI exactly as your healthcare provider tells you to use it.

SKYRIZI is available in a 150 mg/mL prefilled syringe and pen.

Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda/gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

© 2024 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.

US-SKZD-230726

On-screen Text:
Skyrizi®
risankizumab-rzaa